Nicolas Poirier

Company: OSE Immunotherapeutics

Job title: Chief Executive Officer

Seminars:

CLEC1 Novel Myeloid Checkpoint & Cell-Death Sensor, with Application in Oncology & Inflammation 11:00 am

Understanding the biology of CLEC1 to clarify its role as a novel target and explain its mechanism Outlining CLEC1’s function in cancer treatment to underscore its therapeutic potential in this indication Mapping out CLEC1 function in inflammation and comparing its role in oncologyRead more

day: Conference Day One